APOTHEEK LEROY
ActiveAPOTHEEK LEROY has been active since 1992 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.00M and a net result of €382k. Equity is growing by ~14.5% per year across the filed fiscal years. Its solvency ranks better than 85% of 10242 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
100
/ 100
Excellent= vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability64▲+5
Solvency100=
Growth78=
Stability100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €300k at 30 days acceptable
Liquidity ample (current ratio 4.01 against 3.48 in 2024), and 25.4% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
74.6%
Return on assets
9.5%
Age of the figures
8 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-08-2026, 18 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
18 d late
2024
28 d late
2023
28 d late
2022
29 d late
2021
26 d late
2020
30 d late
2019
89 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€3.00M▲ 14.6%
2024 · €2.62M
2018: €1.07M
2019: €1.31M
2020: €1.56M
2021: €1.78M
2022: €2.03M
2023: €2.31M
2024: €2.62M
2018 → 2025
Total assets
€4.03M▲ 8.7%
2024 · €3.70M
2018: €2.06M
2019: €2.31M
2020: €2.60M
2021: €2.80M
2022: €3.14M
2023: €3.40M
2024: €3.70M
2018 → 2025
Net result
€382k▲ 23.4%
2024 · €310k
2018: €248k
2019: €231k
2020: €257k
2021: €214k
2022: €258k
2023: €279k
2024: €310k
2018 → 2025
Working capital
€2.97M▲ 15.4%
2024 · €2.57M
2018: €856k
2019: €1.11M
2020: €1.39M
2021: €1.63M
2022: €1.92M
2023: €2.23M
2024: €2.57M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€1.78M-€2.03M▲ 14.5%€2.31M▲ 13.7%€2.62M▲ 13.4%€3.00M▲ 14.6%
Operating result€407k-€469k▲ 15.2%€504k▲ 7.5%€537k▲ 6.5%€642k▲ 19.7%
Net result€214k-€258k▲ 20.5%€279k▲ 7.9%€310k▲ 11.1%€382k▲ 23.4%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 20% above 2024 and is the highest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €4.03M
Fixed assets
€74k▼ 22.8%
Current assets
€3.95M▲ 9.6%
Equity and liabilities €4.03M
Equity
€3.00M▲ 14.6%
Debt
€1.02M▼ 5.5%
The debt ratio falls from 29.2% to 25.4%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€697k▲
2024 · €579k
Cash flow
€436k▲
2024 · €351k
Solvency
74.6%▲
2024 · 70.8%
Current ratio
4.01▲
2024 · 3.48
Quick ratio
3.55▲
2024 · 3.07
Debt / equity
0.34▼
2024 · 0.41
ROE
12.7%▲
2024 · 11.8%
ROA
9.5%▲
2024 · 8.4%
Interest coverage
7.00▲
2024 · 5.83
Debt
€1.02M▼
2024 · €1.08M
Debt ≤ 1 year
€986k▼
2024 · €1.04M
Income taxes
€174k▲
2024 · €140k
Staff costs
€258k▼
2024 · €258k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€3.70M€4.03M▲
Fixed assets21/28€96k€74k▼
Tangible fixed assets22/27€90k€68k▼
Land and buildings22€51k€25k▼
Plant, machinery and equipment23€38k€43k▲
Furniture and vehicles24€1k€0▼
Financial fixed assets28€6k€6k=
Current assets29/58€3.61M€3.95M▲
Stocks and contracts in progress3€424k€452k▲
Stocks30/36€424k€452k▲
Amounts receivable within one year40/41€272k€346k▲
Trade receivables40€265k€341k▲
Other amounts receivable41€7k€5k▼
Current investments50/53€1.98M€2.23M▲
Cash at bank and in hand54/58€909k€904k▼
Deferred charges and accrued income490/1€19k€20k▲
Equity and liabilities
Total equity and liabilities10/49€3.70M€4.03M▲
Equity10/15€2.62M€3.00M▲
Contributions10/11€750k€750k=
Reserves13€1.87M€2.25M▲
Non-distributable reserves130/1€48k€48k=
Reserves not available under the articles1311€48k€48k=
Tax-exempt reserves132€71€71=
Distributable reserves133€1.82M€2.21M▲
Amounts payable17/49€1.08M€1.02M▼
Amounts payable within one year42/48€1.04M€986k▼
Trade debts44€103k€17k▼
Suppliers440/4€103k€17k▼
Taxes, remuneration and social security45€203k€249k▲
Taxes450/3€48k€82k▲
Remuneration and social security454/9€154k€167k▲
Other amounts payable47/48€731k€720k▼
Accrued charges and deferred income492/3€45k€36k▼
Income statement
Code20242025
Remuneration, social security and pensions62€258k€258k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€42k€54k▲
Other operating charges640/8€14k€7k▼
Gross operating margin9900€851k€961k▲
Operating profit (loss)9901€537k€642k▲
Financial income75/76B€12k€13k▲
Recurring financial income75€12k€13k▲
Financial charges65/66B€99k€100k▲
Recurring financial charges65€99k€100k▲
Profit (loss) for the period before taxes9903€450k€556k▲
Income taxes67/77€140k€174k▲
Profit (loss) for the period9904€310k€382k▲
Profit (loss) for the period to be appropriated9905€310k€382k▲
Appropriation of the result
Profit (loss) to be appropriated9906€310k€382k▲
Transfer to equity691/2€310k€382k▲
To other reserves6921€310k€382k▲
Social balance
Average headcount (FTE)90873.83.8=
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
18-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 18 days late
2025
31-12
Financial
Highest result since 2018net €382k ▲23.4%
Operating result €642k, net result €382k, both a record.
28-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 28 days late
2024
28-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 28 days late
2023
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 29 days late
2022
31-12
Financial
Equity above €2MEq €2.03M ▲14.5%
5 profitable years in a row build equity to €2.03M.
26-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 26 days late
2021
31-12
Financial
Weakest financial yearnet €214k ▼16.8%
Net result drops to €214k, the lowest in the series; recovery starts the following year.
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 30 days late
2020
28-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 89 days late
2019
27-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 27 days late
2018
27-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 27 days late
2017
30-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2002
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Troyentenhoflaan 172600 AntwerpenGround area
1,093 m²
Building footprint
419 m²
Volume, LiDAR
3,920 m³
2 parcels, Flanders · tallest building 16.4 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
Antwerpse Steenweg 117, 9100 Sint-Niklaas
since 20022.060.303.358
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 46445D1484/00S003 | Flanders | 620 m² | 1 · 178 m² | 16.4 m · 3 fl. |
| 11303C0244/00F002 | Flanders | 472 m² | 1 · 241 m² | 15.0 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 · 1 entry · 201 EUR awarded · 201 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2022 | 1 | 201 EUR | 201 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Food safety, FASFC
1 siteSint-Niklaas2.060.303.358
Similar companies · same sector, comparable size
S.P.S.
BE 0450.061.192
Gingelom · Eq €2.99M
APOTHEEK VERHEIJEN
BE 0472.119.190
Ranst · Eq €2.95M
LES PHARMACIES BENIT-DEHAUT-RION
BE 0697.933.014
Dour · Eq €2.95M
DE MAEYER - DE RYCK
BE 0420.105.020
Wommelgem · Eq €2.93M
PHARMACIE LEDOUX-THERASSE
BE 0432.925.549
Courcelles · Eq €2.91M
Of 5,209 companies in sector 47730 we hold annual accounts for 3,851. 1,815 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded11-12-1992
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 33 filingsAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.